DK0789587T4 - Kombineret meningitisvaccine - Google Patents

Kombineret meningitisvaccine

Info

Publication number
DK0789587T4
DK0789587T4 DK95935550T DK95935550T DK0789587T4 DK 0789587 T4 DK0789587 T4 DK 0789587T4 DK 95935550 T DK95935550 T DK 95935550T DK 95935550 T DK95935550 T DK 95935550T DK 0789587 T4 DK0789587 T4 DK 0789587T4
Authority
DK
Denmark
Prior art keywords
meningitis vaccine
combined
combined meningitis
vaccine
combined vaccine
Prior art date
Application number
DK95935550T
Other languages
Danish (da)
English (en)
Other versions
DK0789587T3 (da
Inventor
Costante Ceccarini
Paolo Costantino
Ascenzi Sandro D
Francesco Norelli
Aldo Giannozzi
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10763774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0789587(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Publication of DK0789587T3 publication Critical patent/DK0789587T3/da
Application granted granted Critical
Publication of DK0789587T4 publication Critical patent/DK0789587T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DK95935550T 1994-11-02 1995-11-02 Kombineret meningitisvaccine DK0789587T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9422096A GB9422096D0 (en) 1994-11-02 1994-11-02 Combined meningitis vaccine
PCT/IB1995/001006 WO1996014086A1 (en) 1994-11-02 1995-11-02 Combined meningitis vaccine

Publications (2)

Publication Number Publication Date
DK0789587T3 DK0789587T3 (da) 2003-12-01
DK0789587T4 true DK0789587T4 (da) 2008-08-04

Family

ID=10763774

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95935550T DK0789587T4 (da) 1994-11-02 1995-11-02 Kombineret meningitisvaccine

Country Status (12)

Country Link
US (1) US6251401B1 (cg-RX-API-DMAC7.html)
EP (3) EP2204185A1 (cg-RX-API-DMAC7.html)
JP (3) JP3989951B2 (cg-RX-API-DMAC7.html)
AT (1) ATE246936T1 (cg-RX-API-DMAC7.html)
CA (2) CA2204277C (cg-RX-API-DMAC7.html)
CY (1) CY2423B1 (cg-RX-API-DMAC7.html)
DE (1) DE69531501T3 (cg-RX-API-DMAC7.html)
DK (1) DK0789587T4 (cg-RX-API-DMAC7.html)
ES (1) ES2204967T5 (cg-RX-API-DMAC7.html)
GB (1) GB9422096D0 (cg-RX-API-DMAC7.html)
PT (1) PT789587E (cg-RX-API-DMAC7.html)
WO (1) WO1996014086A1 (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9422096D0 (en) * 1994-11-02 1994-12-21 Biocine Spa Combined meningitis vaccine
US6048527A (en) * 1996-08-27 2000-04-11 Chiron Corporation Antibodies that define unique Meningococcal B epitopes and vaccine compositions
DE69708318T3 (de) 1996-08-27 2006-11-16 Novartis Vaccines and Diagnostics, Inc., Emeryville Neisseria meningitidis serogruppe b glykokonjugate und verfahren zu deren verwendung
JP2002508748A (ja) * 1997-05-01 2002-03-19 カイロン コーポレイション アジュバントとしてのウイルス様粒子の使用
US20040087020A1 (en) 1997-05-28 2004-05-06 Chiron S.P.A. Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin
EP1849860B1 (en) * 1997-05-28 2010-11-17 Novartis Vaccines and Diagnostics S.r.l. Process for preparing an immunogenic factor of Corynebacterium diphtheriae using a culture medium with yeast extract as aminoacid source and no protein complexes of animal origin
US20070259007A1 (en) * 1999-10-19 2007-11-08 Kruzel Marian L Lactoferrin: an adjuvant for vaccines
EP1233784B1 (en) * 1999-12-02 2008-07-09 Novartis Vaccines and Diagnostics, Inc. Compositions and methods for stabilizing biological molecules upon lyophilization
WO2002000249A2 (en) * 2000-06-29 2002-01-03 Glaxosmithkline Biologicals S.A. Multivalent vaccine composition
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
JP2004529643A (ja) 2001-04-17 2004-09-30 カイロン コーポレイション 機能活性抗体を誘発する髄膜炎菌性ｂエピトープの分子模倣物
GB0115176D0 (en) 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
AR045702A1 (es) 2001-10-03 2005-11-09 Chiron Corp Composiciones de adyuvantes.
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
DE60328481D1 (de) * 2002-05-14 2009-09-03 Novartis Vaccines & Diagnostic Schleimhautapplizierter impfstoff, der das adjuvanz chitosan und menigokokkenantigene enthält
GB0302218D0 (en) * 2003-01-30 2003-03-05 Chiron Sri Vaccine formulation & Mucosal delivery
US20030124139A1 (en) * 2002-11-20 2003-07-03 Irina Esikova Compositions and methods for stabilizing biological molecules upon lyophilization
CN102302776B (zh) 2003-01-30 2014-06-18 诺华疫苗和诊断有限公司 抗多种脑膜炎球菌血清组的可注射性疫苗
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
CN103405761A (zh) 2003-10-02 2013-11-27 诺华疫苗和诊断有限公司 多种脑膜炎球菌血清群的液体疫苗
GB0500787D0 (en) * 2005-01-14 2005-02-23 Chiron Srl Integration of meningococcal conjugate vaccination
DK2283857T3 (da) 2005-06-27 2019-10-28 Glaxosmithkline Biologicals Sa Vaccinesammensætning omfattende konjugerede native N. Meningitidis kapselpolysaccharider
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
ES2555786T3 (es) * 2007-06-04 2016-01-08 Glaxosmithkline Biologicals Sa Formulación de vacunas contra la meningitis
ATE553774T1 (de) * 2007-10-19 2012-05-15 Novartis Ag Meningokokkenimpfstoffformulierungen
JP2011506334A (ja) 2007-12-07 2011-03-03 ノバルティス アーゲー 免疫応答を誘導するための組成物
FI2608805T4 (fi) 2010-08-23 2025-08-07 Wyeth Llc NEISSERIA MENINGITIDIS rLP2086 -ANTIGEENIEN STABIILEJA FORMULAATIOITA
CA2809758C (en) 2010-09-10 2021-07-13 Wyeth Llc Non-lipidated variants of neisseria meningitidis orf2086 antigens
MX351993B (es) 2012-03-09 2017-11-03 Pfizer Composiciones de neisseria meningitidis y metodos de las mismas.
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
ES2685894T3 (es) 2013-03-08 2018-10-15 Pfizer Inc. Polipéptidos de fusión inmunogénicos
MX380129B (es) 2013-09-08 2025-03-11 Pfizer Composiciones de neisseria meningitidis y sus metodos
CN107249626A (zh) 2015-02-19 2017-10-13 辉瑞大药厂 脑膜炎奈瑟球菌组合物及其方法
IL267733B2 (en) 2017-01-31 2023-10-01 Pfizer Neisseria meningitidis compositions and methods thereof
MX2022003682A (es) 2019-09-27 2022-04-25 Pfizer Composiciones de neisseria meningitidis y metodos de las mismas.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4451446A (en) * 1982-03-04 1984-05-29 Smithkline-Rit Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them
US4619828A (en) * 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
US4459286A (en) * 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
IT1187753B (it) * 1985-07-05 1987-12-23 Sclavo Spa Coniugati glicoproteici ad attivita' immunogenica trivalente
US5371197A (en) * 1991-09-24 1994-12-06 Merck & Co., Inc. Protein-dimeric polysaccharide conjugate vaccine
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
IT1262896B (it) * 1992-03-06 1996-07-22 Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
GB9422096D0 (en) * 1994-11-02 1994-12-21 Biocine Spa Combined meningitis vaccine
US5628496A (en) 1995-06-07 1997-05-13 Avm, Inc. Pneumatic spring
US6048527A (en) * 1996-08-27 2000-04-11 Chiron Corporation Antibodies that define unique Meningococcal B epitopes and vaccine compositions

Also Published As

Publication number Publication date
EP2204185A8 (en) 2010-10-27
EP2204185A1 (en) 2010-07-07
EP0789587A1 (en) 1997-08-20
ES2204967T3 (es) 2004-05-01
EP1312377A3 (en) 2004-02-04
DE69531501T3 (de) 2008-11-13
CA2204277A1 (en) 1996-05-17
PT789587E (pt) 2003-12-31
JPH10509701A (ja) 1998-09-22
DE69531501D1 (de) 2003-09-18
JP4871770B2 (ja) 2012-02-08
CA2689871A1 (en) 1996-05-17
DK0789587T3 (da) 2003-12-01
EP1312377A2 (en) 2003-05-21
EP0789587B2 (en) 2008-04-02
GB9422096D0 (en) 1994-12-21
JP3989951B2 (ja) 2007-10-10
ATE246936T1 (de) 2003-08-15
DE69531501T2 (de) 2004-06-24
ES2204967T5 (es) 2008-07-01
JP2011016850A (ja) 2011-01-27
JP2007169302A (ja) 2007-07-05
US6251401B1 (en) 2001-06-26
WO1996014086A1 (en) 1996-05-17
CY2423B1 (en) 2004-11-12
EP0789587B1 (en) 2003-08-13
CA2204277C (en) 2010-02-02

Similar Documents

Publication Publication Date Title
ATE246936T1 (de) Kombiniertes menningitis vakzine
DE69630181D1 (de) Anästhesiegerät
DE69528885D1 (de) Software-notizen
FR2717423B1 (fr) Instrument d'écriture.
FR2735031B1 (fr) Appareil d'anesthesie loco-regionale.
FI932264A7 (fi) Paperikoneen kitaformeri
DE69612278D1 (de) Ritzvorrichtung
DE69504878D1 (de) Pneumatische Vorrichtung
FR2736937B1 (fr) Machine d'etirage-texturation par fausse torsion
KR970002725A (ko) 현금 자동 거래 장치
FR2705239B1 (fr) Aiguille clivable.
FR2716759B1 (fr) Etage de formatage d'opérandes optimisé.
KR960020265U (ko) 무균작업대
ITTO910901A1 (it) Procedimento per l'incollaggio di pezzi di lamiera.
FR2707869B1 (fr) Nouvel appareil et instrument d'élimination des bactéries sous-gingivales.
ES1032049Y (es) Dispositivo individual neumatico antitraumatismos.
ES1028831U (es) Poste indicador de parada para cuatro lineas de transporte: compacto, removible, apilable y con soporte publicitario.
KR950000659U (ko) 공압식 소형펀칭기
FR2730784B1 (fr) Amplificateur pneumatique
UA912S (uk) Верстат деревообробний комбінований універсальний
ITSV950018A0 (it) Utensile chirurgico per interventi in laparoscopia.
ES1031730Y (es) Maquina flejadora perfeccionada.
KR940026479U (ko) 화초재배가 되도록 한 상자형 엽서
KR970006014A (ko) 후륜 2축 대형차량의 에이. 비. 에스/에이. 에스. 알 장치
KR960033802U (ko) 서류용 지철구